REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS

REVIEW OF AMERICAN COLLEGE OF RHEUMATOLOGY (ACR) CLINICAL GUIDELINES FOR THE PREVENTION AND TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS

Glucocorticoids (GCs) play an important role in treating many inflammatory diseases due to their anti-inflammatory and immunomodulatory activities and are used in many fields of medicine. Despite their clinical benefits of GCs used to treat patients with chronic inflammatory diseases, prolonged admi...

Full description

Bibliographic Details
Main Author:	N. V. Toroptsova
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2018-05-01
Series:	Научно-практическая ревматология
Subjects:	clinical guidelines osteoporosis glucocorticoids glucocorticoid-induced osteoporosis fracture risk treatment of glucocorticoid-induced osteoporosis
Online Access:	https://rsp.mediar-press.net/rsp/article/view/2518

Similar Items

Glucocorticoid-induced osteoporosis: presentation and comments on the new American College of Rheumatology guidelines
by: Natalia V. Toroptsova
Published: (2018-04-01)

Glucocorticoid-induced osteoporosis: 2013 update
by: M. Mazzantini, et al.
Published: (2014-07-01)

GLUCOCORTICOID-INDUCED OSTEOPOROSIS: DIAGNOSIS, PREVENTION, AND TREATMENT
by: N. V. Toroptsova
Published: (2014-09-01)

Zebrafish models for glucocorticoid-induced osteoporosis
by: Wen-Ying Lin, et al.
Published: (2022-01-01)

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
by: Michaël R. Laurent, et al.
Published: (2022-06-01)

Osteoporosis inducidapor glucocorticoides
by: Maria Lorena Brance, et al.
Published: (2014-09-01)

Osteoporosis secundaria y Osteoporosis inducida por glucocorticoides (OIG)
by: Elías Forero Illera
Published: (2006-01-01)

Glucocorticoids: A review of its adverse effects including bone loss
by: Amit Dua, et al.
Published: (2019-01-01)

Update on Glucocorticoid Induced Osteoporosis
by: Soo-Kyung Cho, et al.
Published: (2021-06-01)

Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway
by: Shumei Li, et al.
Published: (2023-12-01)

Glucocorticoid-Induced Osteoporosis: The Potential Role of Romosozumab
by: Jacqueline So, et al.
Published: (2020-12-01)

An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015
by: Swan Sim Yeap, et al.
Published: (2017-03-01)

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
by: Murphy Daniel R, et al.
Published: (2012-10-01)

glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01)

Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study
by: M. Rossini, et al.
Published: (2017-05-01)

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
by: Kaleen N. Hayes, et al.
Published: (2022-03-01)

Editorial: Glucocorticoid and bone: Friend or foe
by: Ulrike Baschant, et al.
Published: (2022-08-01)

Glucocorticoid-induced osteoporosis – a disorder of mesenchymal stromal cells?
by: Mark Stuart Cooper, et al.
Published: (2011-08-01)

Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Yanbeiy ZA, et al.
Published: (2019-08-01)

Diretrizes para prevenção e tratamento da osteoporose induzida por glicocorticoide Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis
by: Rosa Maria Rodrigues Pereira, et al.
Published: (2012-08-01)

Glucocorticoid-induced osteoporosis: pathogenesis and prevention
by: I. G. Krasivina, et al.
Published: (2020-01-01)

Glucocorticoid-induced osteoporosis; management based on recent major international recommendations
by: Amila Rathnapala, et al.
Published: (2014-01-01)

Analysis of the state-of-the-art of consulting medical care to patients with glucocorticoid-induced osteoporosis or its risk according to the data of a questionnaire survey (GLUCOST study)
by: I A Baranova, et al.
Published: (2015-05-01)

Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway
by: Zeng Chenying, et al.
Published: (2023-06-01)

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
by: Sylvia Thiele, et al.
Published: (2019-07-01)

Update on the Treatment of Glucocorticoid-Induced Osteoporosis
by: Ai Lee Lim, et al.
Published: (2022-06-01)

Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial
by: Toshihiro Nanki, et al.
Published: (2022-12-01)

A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology
by: Mubashir Ahmad, et al.
Published: (2019-10-01)

Indications to teriparatide treatment in patients with osteoporosis
by: R Rizzoli, et al.
Published: (2011-11-01)

Ganoderma lucidum Immune Modulator Protein rLZ-8 Could Prevent and Reverse Bone Loss in Glucocorticoids-Induced Osteoporosis Rat Model
by: Yong Yang, et al.
Published: (2020-05-01)

Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios
by: A. Delle Sedie, et al.
Published: (2011-09-01)

Comparative evaluation of denosumab efficacy of in patients with rheumatoid arthritis and postmenopausal osteoporosis: results of 1-year study in clinical practice
by: O. V. Dobrovolskaya, et al.
Published: (2019-05-01)

Effects of Systemic Glucocorticoid Use on Fracture Risk: A Population-Based Study
by: Ji Weon Koh, et al.
Published: (2020-09-01)

The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
by: Leiming Zhang, et al.
Published: (2021-11-01)

Protective effect of Sika Deer bone polypeptide extract on dexamethasone-induced osteoporosis in rats
by: Liping An, et al.
Published: (2021-07-01)

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes
by: Manuel Gado, et al.
Published: (2022-03-01)

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Chuanjian Yuan, et al.
Published: (2023-06-01)

Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model
by: Gabriele Pizzino, et al.
Published: (2017-09-01)

Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database
by: Byung-Wook Song, et al.
Published: (2022-02-01)

Corrigendum: Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model
by: Gabriele Pizzino, et al.
Published: (2022-11-01)